Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2009-05-08Clinical Trial Update: Randomized Controlled Trial of Home Telemonitoring for Elderly People [NA]
Clinical trial update about a randomized controlled trial of home telemonitoring for elderly people. Diseases listed include diabetes mellit…
-
CLINICAL_TRIALS trial_result · 2009-05-07Clinical Trial Update: Writing About Disease: Effect on Rehabilitation? [NA]
A completed clinical trial update from sponsor LHL Helse examining whether writing about a disease influences rehabilitation outcomes in peo…
-
CLINICAL_TRIALS trial_result · 2009-05-06Clinical Trial Update: Diaphragmatic Mobility and Chronic Obstructive Pulmonary Disease
A completed clinical trial from the University of Sao Paulo evaluated diaphragmatic mobility in chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2009-04-23Clinical Trial Update: IMD-1041 Chronic Obstructive Pulmonary Disease: Proof of Concept (POC) Study [Phase 2]
IMD-1041 is being evaluated in a Phase 2 proof-of-concept trial for Chronic Obstructive Pulmonary Disease, with the current trial status not…
-
CLINICAL_TRIALS trial_result · 2009-04-21Clinical Trial Update: Nutritional Enhancement in Chronic Obstructive Pulmonary Disease (COPD) [NA]
This clinical trial evaluating nutritional enhancement in chronic obstructive pulmonary disease (COPD) has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2009-04-21Clinical Trial Update: Exacerbations and Health Related Quality of Life in Chronic Obstructive Pulmonary Disease
This clinical trial update discusses exacerbations and health-related quality of life in chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2009-04-20Clinical Trial Update: Neuromuscular Electrical Stimulation in Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 study evaluating neuromuscular electrical stimulation in chronic obstructive pulmonary disease has completed and posted results in 2…
-
CLINICAL_TRIALS trial_result · 2009-04-20Clinical Trial Update: Osteopathy in Chronic Obstructive Pulmonary Disease (COPD) Rehabilitation Trial [EARLY_Phase 1]
An early Phase 1 trial evaluating osteopathy in COPD rehabilitation has completed and posted results. The sponsor is Fondazione Salvatore Ma…
-
CLINICAL_TRIALS trial_result · 2009-04-20Clinical Trial Update: Reproducibility of 6 Minute Walk Tests for Oxygen Desaturation
A completed clinical trial assessing the reproducibility of 6-minute walk tests for detecting oxygen desaturation in hypoxemia/anoxia with C…
-
CLINICAL_TRIALS trial_result · 2009-04-09Clinical Trial Update: Dyspnea and Biomarkers in a Prehospital Setting
A prehospital trial examining dyspnea and related biomarkers has completed, evaluating patients with dyspnea and conditions such as heart fa…
-
CLINICAL_TRIALS trial_result · 2009-04-07Clinical Trial Update: Exacerbation and Training in Patients With Chronic Obstructive Pulmonary Disease [NA]
A completed KU Leuven clinical trial in chronic obstructive pulmonary disease investigating exacerbation and training interventions.
-
CLINICAL_TRIALS trial_result · 2009-04-02Clinical Trial Update: Efficacy Safety Study of Arformoterol/Tiotropium Combination Versus Either Therapy Alone in Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]
A Phase 4 study evaluated the efficacy and safety of an arformoterol and tiotropium combination versus each therapy alone in chronic obstruc…
-
FDA approval · 2009-03-31FDA Approved: ADVAIR DISKUS — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for ADVAIR DISKUS (fluticasone propionate and salmeterol) from GlaxoSmithKline LLC. The approval…
-
CLINICAL_TRIALS trial_result · 2009-03-27Clinical Trial Update: A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPD [Phase 3]
Phase 3 trial comparing Symbicort inhaler (budesonide/formoterol) with Formoterol Turbuhaler and placebo in patients with chronic obstructiv…
-
CLINICAL_TRIALS trial_result · 2009-03-27Clinical Trial Update: Efficacy and Safety Study of Symbicort Turbuhaler in Chinese Patients With COPD [Phase 3]
A Phase 3 efficacy and safety study of Symbicort Turbuhaler in Chinese patients with chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2009-03-27Clinical Trial Update: A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and Symbicort® pMDI 2 x 80/4.5 μg Bid With Formoterol Turbuhaler®, Budesonide pMDI, the Combination of Formoterol Turbuhaler® and Budesonide pMDI, and Placebo in COPD Patients [Phase 3]
A completed Phase 3 trial compares several COPD therapies, including Symbicort pMDI with different budesonide/formoterol doses, Formoterol T…
-
CLINICAL_TRIALS trial_result · 2009-03-27Clinical Trial Update: Evaluation of Possible Effects on the QTc Interval of CHF 4226 pMDI in Healthy Volunteers [Phase 1]
Phase 1 trial evaluating whether CHF 4226 pMDI affects QTc interval in healthy volunteers; the study is completed and sponsored by Chiesi Fa…
-
CLINICAL_TRIALS trial_result · 2009-03-23Clinical Trial Update: Multiple Dose Healthy Volunteer Safety Pharmacokinetics Study [Phase 1]
Pfizer completed a Phase 1 multiple-dose safety and pharmacokinetics study in healthy volunteers.
-
FDA approval · 2009-03-20FDA Approved: LEVALBUTEROL — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved Mylan's generic Levalbuterol for treatment or prevention of bronchospasm associated with reversible obstructive airway disease,…
-
CLINICAL_TRIALS trial_result · 2009-03-18Clinical Trial Update: High Frequency Chest Wall Oscillation in Chronic Obstructive Pulmonary Disease (COPD) [NA]
A clinical trial evaluating high frequency chest wall oscillation for chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2009-03-13Clinical Trial Update: Bronchiectasis in Chronic Obstructive Pulmonary Disease (COPD) Patients: Role of Prophylaxis [Phase 2]
A Phase 2 trial from the University of Milan evaluating prophylaxis for bronchiectasis in COPD patients has been terminated.
-
CLINICAL_TRIALS research · 2009-03-06Clinical Trial Update: Doxycycline and Airway Inflammation in Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]
A Phase 4 clinical trial update on doxycycline for airway inflammation in chronic obstructive pulmonary disease, with status currently unkno…
-
CLINICAL_TRIALS trial_result · 2009-03-04Clinical Trial Update: A Crossover Study in the Treatment of Patients With COPD [Phase 3]
This entry notes the completion of a Phase 3 crossover clinical trial in chronic obstructive pulmonary disease sponsored by Dey.
-
FDA approval · 2009-03-03FDA Approved: SPIRIVA HANDIHALER — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for Spiriva HandiHaler (tiotropium bromide) from Boehringer Ingelheim Pharmaceuticals, Inc. The appr…
-
FDA approval · 2009-03-03FDA Approved: IPRATROPIUM BROMIDE — Supplemental Application (NORTHSTAR RX LLC)
FDA approved a supplemental application for a generic ipratropium bromide product from NorthStar RX LLC.